Chronically lowering sympathetic activity protects sympathetic nerves in spleens from aging F344 rats

Journal of Neuroimmunology

Volumn 247, Issue 1-2, 2012, Pages 38-51

  Perez, Sam D ^a   Kozic, Brooke ^a   Molinaro, Christine A ^a   Thyagarajan, Srinivasan ^a   Ghamsary, Mark ^a   Lubahn, Cheri L ^b   Lorton, Dianne ^b,c,d   Bellinger, Denise L ^a  

^a LOMA LINDA UNIVERSITY   (United States)

^b SUN HEALTH RESEARCH INSTITUTE   (United States)

^c KENT STATE UNIVERSITY   (United States)

^d SUMMA HEALTH SYSTEM   (United States)

Author keywords

adrenergic receptors; CAMP production; Imidazoline 1 receptor agonist; Rilmenidine; Splenic norepinephrine turnover; Sympathetic nervous system

Indexed keywords

BETA ADRENERGIC RECEPTOR; CYCLIC AMP; NORADRENALIN; RILMENIDINE;

ADRENERGIC TRANSMISSION; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; FLUORESCENCE HISTOCHEMISTRY; LOW DRUG DOSE; MALE; NEUROPROTECTION; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR DENSITY; SPLEEN; SPLEEN CELL; SPLEEN WEIGHT; SYMPATHETIC NERVE; SYMPATHETIC TONE;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-AGONISTS; AGING; ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; CATECHOLAMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NOREPINEPHRINE; ORGAN SIZE; OXAZOLES; PROPANOLAMINES; PROTEIN BINDING; RANDOM ALLOCATION; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; SPLEEN; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS;

EID: 84860841205     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.03.022     Document Type: Article

References (61)

1. Banerjee M., Sanderson J.D., Spencer J., Dunn-Walters D.K. Immunohistochemical analysis of ageing human B and T cell populations reveals an age-related decline of CD8 T cells in spleen but not gut-associated lymphoid tissue (GALT). Mech. Ageing Dev. 2000, 115:85-99.
2. Bellinger D.L., Ackerman D.K., Felten S.Y., Felten D.L. A longitudinal study of age-related loss of NA nerves and lymphoid cells in the aged rat spleen. Exp. Neurol. 1992, 116:295-311.
3. Bellinger D.L., Madden K.S., Lorton D., ThyagaRajan S., Felten S. Age-related alterations in neural-immune interactions and neural strategies in immunosenescence. Psychoneuroimmunology 2001, 113-160. Academic Press, San Diego. Third edition. R. Ader, D.L. Felten, N. Cohen (Eds.).
4. Bellinger D.L., Tran L., Kang J.I., Lubahn C., Felten, Lorton D.L. Age-related changes in noradrenergic sympathetic innervation of the rat spleen are strain dependent. Brain Behav. Immun. 2002, 16:247-261.
5. Bellinger D.L., Silva D., Millar A.B., Molinaro C., Ghamsary M., Carter J., Lorton D., Lubahn S., ThyagaRajan S. Sympathetic nervous system and lymphocyte proliferation in the Fischer 344 rat spleen: a longitudinal study. Neuroimmunomodulation 2008, 15:260-271.
6. Bellinger D.L., Millar B.A., Perez S., Carter J., Wood C., Thyagarajan S., Molinaro C., Lubahn C., Lorton D. Sympathetic modulation of immunity: relevance to disease. Cell. Immunol. 2008, 252:27-56.
7. Beluli D.J., Weaver L.C. Areas of rostral medulla providing tonic control of renal and splenic nerves. Am. J. Physiol. 1991, 261:H1687-H1692.
8. Bruban V., Feldman J., Greney H., Dontenwill M., Schann S., Jarry C., Payard M., Boutin J., Scalbert E., Pfeiffer B., Renard P., Vanhoutte P., Bousquet P. Respective contribution of alpha-adrenergic and non-adrenergic mechanisms in the hypotensive effect of imidazoline-like drugs. Br. J. Pharmacol. 2001, 133:261-266.
9. Burke S.L., Head G.A. Cardiac and renal baroreflex control during stress in conscious renovascular hypertensive rabbits: effects of rilmenidine. J. Hypertens. 2009, 27:132-141.
10. Burke W.J., Li S.W., Chung H.D., Ruggiero D.A., Kristal B.S., Johnson E.M., Lampe P., Kumar V.B., Franko M., Williams E.A., Zahm D.S. Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: role in neurodegenerative diseases. Neurotoxicology 2004, 25:101-115.
11. Burke S.L., Evans R.G., Head G.A. Effects of chronic sympatho-inhibition on reflex control of renal blood flow and plasma renin activity in renovascular hypertension. Br. J. Pharmacol. 2010, 159:438-448.
12. Chatelain P., Robberecht P., Camus J.C., De Neef P., Waelbroeck M., Roba J., Christophe J. The adenylate cyclase activity in heart membranes from normotensive and spontaneously hypertensive rats, after chemical sympathectomy, suggests the presence of presynaptic secretin receptors. Eur. J. Pharmacol. 1983, 93:271-276.
13. Chen K.B., Lin A.M., Chiu T.H. Oxidative injury to the locus coeruleus of rat brain: neuroprotection by melatonin. J. Pineal Res. 2003, 35:109-117.
14. Chinta S.J., Andersen J.K. Redox imbalance in Parkinson's disease. Biochim. Biophys. Acta 2008, 1780:1362-1367.
15. Cohen S., Miller G.E., Rabin B.S. Psychological stress and antibody response to immunization: a critical review of the human literature. Psychosom. Med. 2001, 63:7-18.
16. Cowen T., Thrasivoulou C. Cerebrovascular nerves in old rats reduced accumulation of 5-hydroxytryptamine and loss of nerve fibres. Brain Res. 1990, 513:237-243.
17. Dampney R.A. Functional organization of central pathways regulating the cardiovascular system. Physiol. Rev. 1994, 74:323-364.
18. Dardonville C., Rozas I. Imidazoline binding sites and their ligands: an overview of the different chemical structures. Med. Res. Rev. 2004, 24:639-661.
19. del Rey A., Besedovsky H.O., Sorkin E., Da Prada M., Bondiolotti G.P. Sympathetic immunoregulation: difference between high- and low-responder animals. Am. J. Physiol. 1982, 242:R30-R33.
20. Dobson J.G., Fray J., Leonard J.L., Pratt R.E. Molecular mechanisms of reduced beta-adrenergic signaling in the aged heart as revealed by genomic profiling. Physiol. Genomics 2003, 15:142-147.
21. Docherty J.R. Age-related changes in adrenergic neuroeffector transmission. Auton. Neurosci. 2002, 96:8-12.
22. Dontenwill M., Vonthron C., Greney H., Magnier C., Heemskerk F., Bousquet P. Identification of human I1 receptors and their relationship to alpha 2-adrenoceptors. Ann. N. Y. Acad. Sci. 1999, 881:123-134.
23. Dunkley P.R., Bobrovskaya L., Graham M.E., von Nagy-Felsobuki E.I., Dickson P.W. Tyrosine hydroxylase phosphorylation: regulation and consequences. J. Neurochem. 2004, 91:1025-1043.
24. Ernsberger P. The I1-imidazoline receptor and its cellular signaling pathways. Ann. N. Y. Acad. Sci. 1999, 881:35-53.
25. Esler M., Jennings G., Korner P., Blombery P., Sacharias N., Leonard P. Measurement of total and organ-specific norepinephrine kinetics in humans. Am. J. Physiol. 1984, 247:E21-E28.
26. Esler M., Lux A., Jennings G., Hastings J., Socratous F., Lambert G. Rilmenidine sympatholytic activity preserves mental and orthostatic sympathetic response and epinephrine secretion. Arch. Mal. Coeur Vaiss. 2004, 97:786-792.
27. Flatmark T. Catecholamine biosynthesis and physiological regulation in neuroendocrine cells. Acta Physiol. Scand. 2000, 168:1-17.
28. Fló J., Massouh E. Age-related changes of naive and memory CD4 rat lymphocyte subsets in mucosal and systemic lymphoid organs. Dev. Comp. Immunol. 1997, 443-453.
29. Goldstein D.S., McEwen B. Allostasis, homeostats, and the nature of stress. Stress 2002, 5:55-58.
30. Göthert M., Brüss M., Bönisch H., Molderings G.J. Presynaptic imidazoline receptors. New developments in characterization and classification. Ann. N. Y. Acad. Sci. 1999, 881:171-184.
31. Halper J.P., Mann J.J., Weksler M.E., Bilezikian J.P., Sweeney J.A., Brown R.P., Golbourne T. Beta adrenergic receptors and cyclic AMP levels in intact human lymphocytes: effects of age and gender. Life Sci. 1984, 35:855-863.
32. Jiang D., Fei R.G., Pendergrass W.R., Wolf N.S. An age-related reduction in the replicative capacity of two murine hematopoietic stroma cell types. Exp. Hematol. 1992, 20:1216-1222.
33. Jinsmaa Y., Florang V.R., Rees J.N., Anderson D.G., Strack S., Doorn J.A. Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate. Chem. Res. Toxicol. 2009, 22:835-841.
34. Kim K., Cho S.C., Cova A., Jang I.S., Park S.C. Alterations of epinephrine-induced gluconeogenesis in aging. Exp. Mol. Med. 2009, 41:334-340.
35. Kimura K., Fusano T., Tanaka Y. A scanning and transmission electron microscopic study of contractile trabecules in the rat spleen. Okajimas Folia Anat. Jpn. 2001, 78:187-199.
36. Kumer S.C., Vrana K.E. The intricate regulation of tyrosine hydroxylase activity and gene expression. J. Neurochem. 1996, 67:443-462.
37. Kyrou I., Tsigos C. Stress hormones: physiological stress and regulation of metabolism. Curr. Opin. Pharmacol. 2009, 9:787-793.
38. McAllen R.M., May C.N., Shafton A.D. Functional anatomy of sympathetic premotor cell groups in the medulla. Clin. Exp. Hypertens. 1995, 17:209-221.
39. McCarty R. Cardiovascular responses to acute footshock stress in adult and aged Fischer 344 male rats. Neurobiol. Aging 1985, 6:47-50.
40. McCarty R., Pacak K., Goldstein D.S., Eisenhofer G. Regulation of peripheral catecholamine responses to acute stress in young adult and aged F-344 rats. Stress 1997, 2:113-122.
41. Monassier L., Greney H., Bousquet P. Chronic treatment with rilmenidine in spontaneously hypertensive rats: differences between two schedules of administration. J. Cardiovasc. Pharmacol. 2004, 43:394-401.
42. Morgenroth V.H., Boadle-Biber M., Roth R.H. Tyrosine hydroxylase: activation by nerve stimulation. Proc. Natl. Acad. Sci. U. S. A. 1974, 71:4283-4287.
43. Pachówka M., Makula J., Korczak-Kowalska G. Diminished cytokines gene expression in lymphoid organs of healthy aged rats. Cytokine 2011, 54:24-28.
44. Parrish D.C., Gritman K., Van Winkle D.M., Woodward W.R., Bader M., Habecker B.A. Postinfarct sympathetic hyperactivity differentially stimulates expression of tyrosine hydroxylase and norepinephrine transporter. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H99-H106.
45. Redwine L., Snow S., Mills P., Irwin M. Acute psychological stress: effects on chemotaxis and cellular adhesion molecule expression. Psychosom. Med. 2003, 65:598-603.
46. Reed M.C., Lieb A., Nijhout H.F. The biological significance of substrate inhibition: a mechanism with diverse functions. Bioessays 2010, 32:422-429.
47. Reis D.J. Neurons and receptors in the rostroventrolateral medulla mediating the antihypertensive actions of drugs acting at imidazoline receptors. J. Cardiovasc. Pharmacol. 1996, 27:S11-S18.
48. Sabatino F., Masoro E.J., McMahan C.A., Kuhn R.W. Assessment of the role of the glucocorticoid system in aging processes and in the action of food restriction. J. Gerontol. 1991, 46:B171-B179.
49. Sabban E.L., Liu X., Serova L., Gueorguiev V., Kvetnansky R. Stress triggered changes in gene expression in adrenal medulla: transcriptional responses to acute and chronic stress. Cell. Mol. Neurobiol. 2006, 26:845-856.
50. Schutzer W.E., Reed J.F., Mader S.L. Decline in caveolin-1 expression and scaffolding of G protein receptor kinase-2 with age in Fischer 344 aortic vascular smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H2457-H2464.
51. Spengler R.N., Allen R.M., Remick D.G., Strieter R.M., Kunkel S.L. Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J. Immunol. 1990, 145:1430-1434.
52. Staehelin M., Müller P., Portenier M., Harris A.W. Beta-adrenergic receptors and adenylate cyclase activity in murine lymphoid cell lines. J. Cyclic Nucleotide Protein Phosphor. Res. 1985, 10:55-64.
53. Stewart I.B., McKenzie D.C. The human spleen during physiological stress. Sports Med. 2002, 32:361-369.
54. Stirling D.P., Stys P.K. Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulation. Trends Mol. Med. 2010, 16:160-170.
55. Szabo B. Imidazoline antihypertensive drugs: a critical review on their mechanism of action. Pharmacol. Ther. 2002, 93:1-35.
56. ThyagaRajan S., Madden K.S., Stevens S.Y., Felten D.L. Restoration of splenic noradrenergic nerve fibers and immune reactivity in old F344 rats: a comparison between l-deprenyl and l-desmethyldeprenyl. Int. J. Immunopharmacol. 2000, 22:523-536.
57. Tsai H., Pottorf W.J., Buchholz J.N., Duckles S.P. Adrenergic nerve smooth endoplasmic reticulum calcium buffering declines with age. Neurobiol. Aging 1998, 19:89-96.
58. Tumer N., Houck W.T., Roberts J. Effect of age on upregulation of the cardiac adrenergic beta receptors. J. Gerontol. 1990, 45:B48-B51.
59. Uchida S., Nishida A., Hara K., Kamemoto T., Suetsugi M., Fujimoto M., Watanuki T., Wakabayashi Y., Otsuki K., McEwen B.S., Watanabe Y. Characterization of the vulnerability to repeated stress in Fischer 344 rats: possible involvement of microRNA-mediated down-regulation of the glucocorticoid receptor. Eur. J. Neurosci. 2008, 27:2250-2261.
60. Wallace L.J. A small dopamine permeability of storage vesicle membranes and end product inhibition of tyrosine hydroxylase are sufficient to explain changes occurring in dopamine synthesis and storage after inhibition of neuron firing. Synapse 2007, 61:715-723.
61. Wong C.P., Magnusson K.R., Ho E. Aging is associated with altered dendritic cells subset distribution and impaired proinflammatory cytokine production. Exp. Gerontol. 2010, 45:163-169.